InMode (INMD) Net Income towards Common Stockholders Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -11.74% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 98.96% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 122.60% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 89.28% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -30.10% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | InMode | 3.41 | -384.57 Mn | 61.55 Mn | -36.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -36.15% |
| Dec 31, 2025 | -2.85% |
| Sep 30, 2025 | -55.97% |
| Jun 30, 2025 | 14.59% |
| Mar 31, 2025 | -13.80% |
| Dec 31, 2024 | -46.46% |
| Sep 30, 2024 | 13.27% |
| Jun 30, 2024 | -60.26% |
| Mar 31, 2024 | -41.12% |
| Dec 31, 2023 | -5.79% |
| Sep 30, 2023 | -4.77% |
| Jun 30, 2023 | 40.75% |
| Mar 31, 2023 | 25.15% |
| Dec 31, 2022 | 21.21% |
| Sep 30, 2022 | 20.61% |
| Jun 30, 2022 | 17.98% |
| Mar 31, 2022 | 32.31% |
| Dec 31, 2021 | 46.06% |
| Sep 30, 2021 | 66.65% |
| Jun 30, 2021 | 299.31% |
| Mar 31, 2021 | 113.27% |
| Dec 31, 2020 | 87.43% |
| Sep 30, 2020 | 62.44% |
| Jun 30, 2020 | -36.42% |
| Mar 31, 2020 | 21.34% |
| Dec 31, 2019 | 2,229.90% |
| Sep 30, 2019 | 87.52% |
| Jun 30, 2019 | 107.37% |